发明名称 The citrate salt of 5, 8, 14-triazatetracyclo (10.3.1.02,11.04.9)-hexadeca-2.(11),3,5,7,9-pentaene
摘要 The citrate salt of 5, 8, 14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene, and pharmaceutical compositions thereof are described. The application is also directed to the various forms of the citrate salt, particularly its hydrate and its anhydrous/nearly anhydrous polymorph. The aforementioned compound is described as being useful in the treatment of inflammatory bowel disease, ulcerative colitis, Crohn's disease, and the like. It is also described as being used in medicaments for the treatment of many other disorders including trauma, AIDS and Tourette's syndrome.
申请公布号 NZ528209(A) 申请公布日期 2004.09.24
申请号 NZ20020528209 申请日期 2002.04.26
申请人 PFIZER PRODUCTS INC 发明人 JOHNSON, PHILLIP JAMES;ROSE, PETER ROBERT;WINT, LEWIN THEOPHILUS;WILLIAMS, GLENN ROBERT
分类号 C07D487/08;A61K;A61K31/495;A61K31/529;A61P;A61P1/04;A61P3/04;A61P5/14;A61P9/06;A61P9/12;A61P17/00;A61P17/02;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/10;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/36;A61P27/00;A61P29/00;A61P31/18;A61P39/02;C07D;C07D221/00;C07D223/00;C07D471/08;(IPC1-7):C07D471/08 主分类号 C07D487/08
代理机构 代理人
主权项
地址